NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Free Report) in a research note published on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Trading Up 2.7 % Shares of NYSEAMERICAN NBY opened at $0.77 on Tuesday. The firm has a market capitalization of $1.44 million, […]

Related Keywords

United States , ,Armistice Capital ,Renaissance Technologies ,News Ratings For Novabay Pharmaceuticals Daily ,Novabay Pharmaceuticals Company Profile ,Novabay Pharmaceuticals Trading ,Novabay Pharmaceuticals Inc ,Novabay Pharmaceuticals ,Virtu Financial ,Free Report ,Bay Pharmaceuticals ,Avenova Spray ,Novabay Pharmaceuticals Daily ,Nyseamerican Nby ,Anby ,Medical ,Initiated Coverage ,Stocknews Com ,